ישראל - עברית - Ministry of Health

medici medical ltd, israel - hepatitis a vaccines - תרחיף להזרקה - hepatitis a vaccines 160 au / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - for active immunisation against infection caused by hepatitis a virus in adults and adolescents over the age of 15

ישראל - עברית - Ministry of Health

sanofi israel ltd - hepatitis a vaccines - תרחיף להזרקה - hepatitis a vaccines 80 units / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - avaxim 80 u pediatric is indicated for active immunisation against infection caused by hepatitis a virus in children aged from 12 months to 15 years inclusive, who are at risk either of contaminating or spreading infection or of a life threatening disease if infected.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - hepatitis a virus antigen, inactivated - תרחיף להזרקה - hepatitis a virus antigen, inactivated 720 e.l.u / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - havrix junior monodose vaccine is indicated for active immunisation against hav infection. the vaccine is particularly indicated for those at increased risk of infection or transmission.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - hepatitis a virus antigen, inactivated - תרחיף להזרקה - hepatitis a virus antigen, inactivated 1440 e.l.u/ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - active immunisation against infections caused by hepatitis a virus.the vaccine is particularly indicated for those at increased risk of infection or transmission.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - תמיסה לאינפוזיה - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - hepatitis b immunoglobulin - תמיסה להזרקה - hepatitis b immunoglobulin 312 iu/ml - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b recurrence following liver transplantation : hepagam b is indicated for the prevetion of hepatitis b recurrence following liver transplantation in hbsag-positive liver transplant patients. hepagam b should be administered intravenously for this indication.postexposure prophylaxis : hepagam b is indicated for the treatment of acute exposure to blood containing hbsag perinatal exposure of infants born to hbsag-positive mothers sexual exposure to hbsag-positive persons and household exposure to persons with acute hbv infection in the following settings: acute exposure to blood containing hbsag following either parenteral exposure (needlestick bite sharps) direct mucous membrane contact (accidental splash) or oral ingestion (pipetting accident) involving hbsag - positive materials such as blood plasma or serum. perinatal exposure of infants born to hbsag-positive mothers infants born to mothers positive for hbsag with or without hbeag. perinatal exposure of infants born to hbsag-positive

ישראל - עברית - Ministry of Health

scivac ltd, israel - hepatitis b vaccines - תרחיף להזרקה - hepatitis b vaccines 10 mcg/ml - hepatitis b, purified antigen - hepatitis b, purified antigen - for active immunization against hepatitis b virus. in high dose: it is indicated for imunization of neonates & children in highly endemic areas.

ישראל - עברית - Ministry of Health

scivac ltd, israel - hepatitis b vaccines - תרחיף להזרקה - hepatitis b vaccines 2.5 mcg / 0.5 ml - hepatitis b, purified antigen - hepatitis b, purified antigen - for active immunization against hepatitis b virus. in high dose: it is indicated for immunization of neonates & children in highly endemic areas.

ישראל - עברית - Ministry of Health

scivac ltd, israel - hepatitis b vaccines - תרחיף להזרקה - hepatitis b vaccines 5 mcg / 0.5 ml - hepatitis b, purified antigen - hepatitis b, purified antigen - for active immunization against hepatitis b virus. in high dose: it is indicated for immunization of neonates & children in highly endemic areas.

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - hepatitis a virus antigen, inactivated - תרחיף להזרקה - hepatitis a virus antigen, inactivated 25 units / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - vaqta is indicated for active pre-exposure prophylaxis against disease caused by hepatitis a virus in children and adolescents 12 months of age and older .